What is EverlyWell?
Founded in 2015 and headquartered in Austin, Texas, EverlyWell operates at the intersection of consumer wellness and clinical diagnostics. The company provides a streamlined digital platform that connects consumers with lab partners, facilitating the delivery of at-home testing kits for a wide range of health markers, including fertility, food sensitivity, thyroid function, and infectious diseases. By digitizing the diagnostic process, EverlyWell has effectively lowered the barrier to entry for routine health monitoring, positioning itself as a critical player in the shift toward decentralized healthcare delivery.
How much funding has EverlyWell raised?
EverlyWell has raised a total of $304.5M across 5 funding rounds:
Angel/Seed
$2.5M
Angel/Seed
$2M
Unspecified
$50M
Series D
$175M
Private Equity
$75M
Angel/Seed (2016): $2.5M, investors not publicly disclosed
Angel/Seed (2017): $2M led by Full Tilt Capital, Jack Novak, NextGen Venture Partners, and SoGal Ventures
Unspecified (2019): $50M supported by NextGen Venture Partners, Highland Capital Partners, Goodwater Capital, Next Coast Ventures, and SoGal Ventures
Series D (2020): $175M featuring Morningside Ventures, Goodwater Capital, Greenspring Associates, The Chernin Group, Lux Capital, Foresite Capital, BlackRock, Portfolia, Highland Capital Partners, and Next Coast Ventures
Private Equity (2021): $75M backed by HealthQuest Capital
Key Investors in EverlyWell
BlackRock
BlackRock is a global investment management firm that provides institutional clients and individual investors with comprehensive risk management, advisory services, and a diverse portfolio of investment strategies across multiple asset classes.
Goodwater Capital
Goodwater Capital is a consumer tech investment firm focused on empowering entrepreneurs to create positive change through innovative solutions in sectors such as healthcare, financial services, and retail.
Greenspring Associates
Greenspring Associates is a venture capital firm that acts as a lifecycle partner for entrepreneurs and fund managers, providing primary and secondary investment support across various stages and geographies.
What's next for EverlyWell?
With the support of its latest capital injection, EverlyWell is well-positioned to accelerate its market penetration and enhance its digital diagnostic capabilities. The company's strategic focus likely involves deepening its integration with existing healthcare ecosystems and broadening its test menu to address emerging consumer health needs. As the demand for remote, data-driven health insights continues to rise, EverlyWell's ability to leverage its established network of lab partners and its robust consumer-facing platform will be instrumental in maintaining its competitive advantage in the rapidly maturing health-tech market.
See full EverlyWell company page
